NeutriSci International Inc. (TSXV:NU), a nutraceutical stock, got a lift after announcing a MOU to develop and distribute THC and CBD infused sublingual tablets
Appetizing cannabis news sparked a bit of speculation in a nutraceutical stock Wednesday. Here’s some small stocks making big moves on Wednesday, May 30, 2018 (as of 4 pm EST):
NeutriSci International Inc. (TSXV:NU), a nutraceutical stock, climbed 44% to $0.13 on Wednesday after announcing that it has entered into a binding Memorandum of Understanding with Nutritional High International Inc. (CSE:EAT) to develop, manufacture and distribute THC and CBD infused sublingual tablets utilizing NeutriSci’s technology, proprietary ingredients and formulations.
As well, shares of VersaPay Corporation (TSXV:VPY) slid 15% to $2.25 as the financial technology company said its total operating expense for the first quarter of 2018 increased by 60% to $3.44 million.
Theralase Technologies Inc. (TSXV:TLT), meanwhile, reported that it has successfully completed its Phase Ib non-muscle invasive bladder cancer clinical study. Theralase Technologies stock popped 24% to $0.385 following the announcement.
Finally, Fintech Select Ltd. (TSXV:FTEC) shares gained as much as 17% before ending unchanged at $0.115 after the provider of pre-paid card programs, mobile banking solutions and cryptocurrency technologies announced that it has recorded a net profit of $986,000 during its first quarter of 2018.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
NeutriSci International Inc. (TSXV:NU), a nutraceutical stock, climbed 44% to $0.13 on Wednesday after announcing that it has entered into a binding Memorandum of Understanding with Nutritional High International Inc. (CSE:EAT) to develop, manufacture and distribute THC and CBD infused sublingual tablets utilizing NeutriSci’s technology, proprietary ingredients and formulations.
